A total of 4 result was found. Results that relate to LI Xiaodong

• The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia

  QIAN Xinhang GU Jiamin LU Peiwen YANG Shisong FANG Cheng LI Xiaodong ZENG Xiantao DOI：10.12173/j.issn.1004-5511.202312069

  Benign prostatic hyperplasia Biomarkers Multi-omics analysis Aging

  Details Download Mobile

• Transurethral plasmakinetic resection of prostate in high-risk benign prostatic hyperplasia patients: a multicenter prospective study

  LI Fei GENG Jie CHEN Hongbo ZHOU Zhijun LIU Xiaohua SHI Hongbo DU Dan ZHU Tao ZHANG Jingyu LI Xiaodong QUE Hui SONG Hongfei YAO Qisheng DOU  Zhongling RUAN Jianzhong ZHENG Jiang ZHU Ziqing REN Xuanyi HUANG Qiao GONG Kan LIU Tongzu HE Dalin ZENG Xiantao DOI：10.12173/j.issn.1004-5511.202402013

  Transurethral plasmakinetic resection of prostate Benign prostatic hyperplasia High-risk patients Cardiovascular diseases

  Details Download Mobile

• Analysis of the disease burden of benign prostatic hyperplasia in China, the United States and Germany at 1990 and 2019

  LU Peiwen ZI Hao QIAN Xinhang MING Daojing FANG Cheng LI Xiaodong DOI：10.12173/j.issn.1004-5511.202403012

  Benign prostatic hyperplasia Disease burden Prevalence rate Incidence rate Years lived with disability

  Details Download Mobile

• Definition and literature of evidence-based urology: a systematic review

  WANG Yunyun CHEN Zheng ZHONG Quliang HUANG Xing XU Xiaofeng LI Xiaodong ZI  Hao JIN Yinghui LI Binghui WENG Hong DONG Zhilong ZENG Xiantao DOI：10.12173/j.issn.1004-5511.202402068

  Evidence-based medicine Evidence-based urology Definition Methodology Systematic review

  Details Download Mobile